-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Gyre Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- Gyre Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $1.5M, a 28.2% decline year-over-year.
- Gyre Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $8.42M, a 8.84% decline year-over-year.
- Gyre Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $8.52M, a 67% increase from 2022.
- Gyre Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $5.1M.
- Gyre Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2014 was $3.48M, a 49671% increase from 2013.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)